BeiGene Ltd ADR buy Royal Bank of Canada
Start price
12.09.23
/
50%
€191.00
Target price
12.09.24
€241.54
Performance (%)
-9.42%
Price
22:26
€175.00
Summary
This prediction is currently active. With a performance of -9.42%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 12.09.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
BeiGene Ltd ADR | 0.000% | 0.000% |
iShares Core DAX® | 4.097% | 1.280% |
iShares Nasdaq 100 | 5.110% | -0.741% |
iShares Nikkei 225® | 5.333% | -0.280% |
iShares S&P 500 | 3.487% | -0.006% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread BeiGene Ltd ADR diskutieren
BeiGene, Ltd. (NASDAQ: BGNE) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $259.00 price target on the stock.
Ratings data for BGNE provided by MarketBeat